HRTX Dividend History & Analysis | N/A Yield

HRTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of January 2026, Heron Therapeuti (HRTX) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 390,557 M 4.30% 7.87%
AMGN 183,880 M 3.21% 5.86%
GILD 168,663 M 2.79% 5.88%
HLN 46,579 M 1.76% 2.46%
REGN 80,328 M 0.54% 0.70%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,438 M 134% 95.6%
HLN 46,579 M 30.1% 100%
AMGN 183,880 M 7.84% 100%
BIM 14,595 M 9.76% 96.0%
ABBV 390,557 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
 3.21% Yield
GILD
Gilead Sciences
 2.79% Yield

HRTX Dividend History: as of January 2026

No dividends paid yet.

HRTX Dividend FAQ

Heron Therapeutics (NASDAQ:HRTX) is a commercial-stage biotech that leverages its proprietary Biochronomer delivery platform to extend the exposure of short-acting drugs, enabling single-dose regimens that last from days to weeks. Its current marketed products include SUSTOL (granisetron) for chemotherapy-induced nausea and vomiting (CINV) in moderate-risk regimens and CINVANTI (IV aprepitant) for high- and moderate-risk CINV, while its pipeline features ZYNRELEF (bupivacaine/meloxicam) for postoperative pain and APONVIE (IV NK-1 antagonist) for postoperative nausea and vomiting.

What is the Dividend Yield of HRTX?

As of January 2026, HRTX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.32.

Does HRTX pay a dividend?

As of January 2026 HRTX does not pay a dividend.

How often does HRTX pay dividends?

Over the last 12 months, HRTX has issued dividend payments.

HRTX dividend forecast

Based on historical data, the forecasted dividends per share for HRTX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).
This suggests the dividend will remain relatively stable.

Will HRTX pay dividends in 2026?

The next Ex-Dividend date for Heron Therapeuti (HRTX) is currently unknown.

What is the next Ex-Dividend Date for HRTX?

The next Ex-Dividend date for Heron Therapeuti (HRTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of HRTX?

HRTX's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of HRTX?

HRTX's 5-Year Yield on Cost is -%. If you bought HRTX's shares at 18.32 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of HRTX?

HRTX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does HRTX have a good Dividend Yield?

HRTX`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of HRTX?

The Dividend Payout Ratio of HRTX is unknown.

What is the Dividend Rating of HRTX?

HRTX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

HRTX Outstanding Shares Analysis

What is the Trend in HRTX's Outstanding Shares?

Heron Therapeuti's outstanding shares have increased by approximately 6.47% annually over the past 3 years (Trend Reliability: 100.0%).

Watch carefully: The company is issuing new shares, diluting existing shareholders. Dividend growth may lag earnings growth as payouts are spread across more shares.

Has HRTX ever had a Stock Split?

Yes, the last stock split was on Jan 13, 2014 with a ratio of 1:20.

This was a reverse split: Multiple shares were consolidated into fewer shares, increasing the price per share. This is sometimes used to meet exchange listing requirements and can be a warning sign if the company is struggling.

Year Number of Shares Annual Growth Rate
1987 107,600
1988 112,700 +4.74%
1989 118,900 +5.5%
1990 121,300 +2.02%
1991 122,500 +0.99%
1992 161,200 +31.59%
1993 170,600 +5.83%
1994 184,400 +8.09%
1995 216,900 +17.62%
1996 230,200 +6.13%
1997 247,700 +7.6%
1998 251,100 +1.37%
1999 251,700 +0.24%
2000 252,800 +0.44%
2001 254,500 +0.67%
2002 255,900 +0.55%
2003 258,200 +0.9%
2004 313,100 +21.26%
2005 315,100 +0.64%
2006 316,600 +0.48%
2007 1,538,700 +386.01%
2008 1,543,400 +0.31%
2009 1,971,000 +27.71%
2010 1,993,000 +1.12%
2011 10,002,000 +401.86%
2012 15,111,000 +51.08%
2013 18,708,000 +23.8%
2014 29,210,000 +56.14%
2015 36,022,000 +23.32%
2016 39,280,000 +9.04%
2017 64,724,000 +64.78%
2018 78,086,000 +20.64%
2019 89,112,000 +14.12%
2020 91,081,000 +2.21%
2021 101,978,000 +11.96%
2022 119,155,000 +16.84%
2023 150,285,000 +26.13%
2024 153,151,000 +1.91%
2025 170,348,000 +11.23%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-01-30 14:20